Tumor protein D52 (TPD52) and cancer—oncogene understudy or understudied oncogene?

The Tumor protein D52 ( TPD52 ) gene was identified nearly 20 years ago through its overexpression in human cancer, and a substantial body of data now strongly supports TPD52 representing a gene amplification target at chromosome 8q21.13. This review updates progress toward understanding the signifi...

Full description

Saved in:
Bibliographic Details
Published in:Tumor biology 2014-08, Vol.35 (8), p.7369-7382
Main Authors: Byrne, Jennifer A., Frost, Sarah, Chen, Yuyan, Bright, Robert K.
Format: Article
Language:English
Subjects:
Animals
Biomarkers, Tumor - blood
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer Research
Cell Line, Tumor
Cell Survival
Chromosomes, Human, Pair 8
DNA Damage
Gene Amplification
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs - physiology
Mutation
Neoplasm Proteins - blood
Neoplasm Proteins - genetics
Neoplasm Proteins - immunology
Neoplasm Proteins - physiology
Oncogenes
Protein expression
Review
Tumorigenesis
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Tumor protein D52 ( TPD52 ) gene was identified nearly 20 years ago through its overexpression in human cancer, and a substantial body of data now strongly supports TPD52 representing a gene amplification target at chromosome 8q21.13. This review updates progress toward understanding the significance of TPD52 overexpression and targeting, both in tumors known to be characterized by TPD52 overexpression/amplification, and those where TPD52 overexpression/amplification has been recently or variably reported. We highlight recent findings supporting microRNA regulation of TPD52 expression in experimental systems and describe progress toward deciphering TPD52’s cellular functions, particularly in cancer cells. Finally, we provide an overview of TPD52’s potential as a cancer biomarker and immunotherapeutic target. These combined studies highlight the potential value of genes such as TPD52 , which are overexpressed in many cancer types, but have been relatively understudied.
ISSN:1010-4283
1423-0380
DOI:10.1007/s13277-014-2006-x